These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 33625995)

  • 21. Differential mRNA expression in ileal and colonic biopsies in irritable bowel syndrome with diarrhea or constipation.
    Camilleri M; Magnus Y; Carlson P; Wang XJ; Chedid V; Maselli D; Taylor A; McKinzie S; Kengunte Nagaraj N; Busciglio I; Nair A
    Am J Physiol Gastrointest Liver Physiol; 2022 Aug; 323(2):G88-G101. PubMed ID: 35502856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fecal short-chain fatty acids in non-constipated irritable bowel syndrome: a potential clinically relevant stratification factor based on catabotyping analysis.
    Gargari G; Mantegazza G; Taverniti V; Gardana C; Valenza A; Rossignoli F; Barbaro MR; Marasco G; Cremon C; Barbara G; Guglielmetti S
    Gut Microbes; 2023 Dec; 15(2):2274128. PubMed ID: 37910479
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristic dysbiosis of gut microbiota of Chinese patients with diarrhea-predominant irritable bowel syndrome by an insight into the pan-microbiome.
    Wang Z; Xu CM; Liu YX; Wang XQ; Zhang L; Li M; Zhu SW; Xie ZJ; Wang PH; Duan LP; Zhu HQ
    Chin Med J (Engl); 2019 Apr; 132(8):889-904. PubMed ID: 30958430
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does Fibre-fix provided to people with irritable bowel syndrome who are consuming a low FODMAP diet improve their gut health, gut microbiome, sleep and mental health? A double-blinded, randomised controlled trial.
    Yan R; Murphy M; Genoni A; Marlow E; Dunican IC; Lo J; Andrew L; Devine A; Christophersen CT
    BMJ Open Gastroenterol; 2020 Aug; 7(1):. PubMed ID: 32816830
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increase in fecal primary bile acids and dysbiosis in patients with diarrhea-predominant irritable bowel syndrome.
    Duboc H; Rainteau D; Rajca S; Humbert L; Farabos D; Maubert M; Grondin V; Jouet P; Bouhassira D; Seksik P; Sokol H; Coffin B; Sabaté JM
    Neurogastroenterol Motil; 2012 Jun; 24(6):513-20, e246-7. PubMed ID: 22356587
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome.
    El-Salhy M; Casen C; Valeur J; Hausken T; Hatlebakk JG
    World J Gastroenterol; 2021 May; 27(18):2219-2237. PubMed ID: 34025075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut Microbiota-Derived Metabolites in Irritable Bowel Syndrome.
    Xiao L; Liu Q; Luo M; Xiong L
    Front Cell Infect Microbiol; 2021; 11():729346. PubMed ID: 34631603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monocarboxylate 4 mediated butyrate transport in a rat intestinal epithelial cell line.
    Kekuda R; Manoharan P; Baseler W; Sundaram U
    Dig Dis Sci; 2013 Mar; 58(3):660-7. PubMed ID: 23344966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and membrane localization of MCT isoforms along the length of the human intestine.
    Gill RK; Saksena S; Alrefai WA; Sarwar Z; Goldstein JL; Carroll RE; Ramaswamy K; Dudeja PK
    Am J Physiol Cell Physiol; 2005 Oct; 289(4):C846-52. PubMed ID: 15901598
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vasoactive Intestinal Polypeptide and Mast Cells Regulate Increased Passage of Colonic Bacteria in Patients With Irritable Bowel Syndrome.
    Bednarska O; Walter SA; Casado-Bedmar M; Ström M; Salvo-Romero E; Vicario M; Mayer EA; Keita ÅV
    Gastroenterology; 2017 Oct; 153(4):948-960.e3. PubMed ID: 28711627
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of an Intestinal Microbiota Signature Associated With Severity of Irritable Bowel Syndrome.
    Tap J; Derrien M; Törnblom H; Brazeilles R; Cools-Portier S; Doré J; Störsrud S; Le Nevé B; Öhman L; Simrén M
    Gastroenterology; 2017 Jan; 152(1):111-123.e8. PubMed ID: 27725146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in fecal short-chain fatty acids following fecal microbiota transplantation in patients with irritable bowel syndrome.
    El-Salhy M; Valeur J; Hausken T; Gunnar Hatlebakk J
    Neurogastroenterol Motil; 2021 Feb; 33(2):e13983. PubMed ID: 32945066
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fecal Microbiota in Patients with Irritable Bowel Syndrome Compared with Healthy Controls Using Real-Time Polymerase Chain Reaction: An Evidence of Dysbiosis.
    Shukla R; Ghoshal U; Dhole TN; Ghoshal UC
    Dig Dis Sci; 2015 Oct; 60(10):2953-62. PubMed ID: 25784074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of butyrate uptake by nontransformed intestinal epithelial cell lines.
    Gonçalves P; Araújo JR; Martel F
    J Membr Biol; 2011 Mar; 240(1):35-46. PubMed ID: 21286694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Archaea influence composition of endoscopically visible ileocolonic biofilms.
    Orgler E; Baumgartner M; Duller S; Kumptisch C; Hausmann B; Moser D; Khare V; Lang M; Köcher T; Frick A; Muttenthaler M; Makristathis A; Moissl-Eichinger C; Gasche C
    Gut Microbes; 2024; 16(1):2359500. PubMed ID: 38825783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of butyrate in electrogenic K
    Inagaki A; Hayashi M; Andharia N; Matsuda H
    Pflugers Arch; 2019 Feb; 471(2):313-327. PubMed ID: 30250967
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subacute ruminal acidosis suppressed the expression of MCT1 in rumen of cows.
    Zhao C; Wang Y; Peng Z; Sun X; Sun G; Yuan X; Li X; Liu G
    J Cell Physiol; 2019 Jul; 234(7):11734-11745. PubMed ID: 30536938
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fecal short-chain fatty acids in patients with diarrhea-predominant irritable bowel syndrome: in vitro studies of carbohydrate fermentation.
    Treem WR; Ahsan N; Kastoff G; Hyams JS
    J Pediatr Gastroenterol Nutr; 1996 Oct; 23(3):280-6. PubMed ID: 8890079
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Methane and fatty acid metabolism pathways are predictive of Low-FODMAP diet efficacy for patients with irritable bowel syndrome.
    Eetemadi A; Tagkopoulos I
    Clin Nutr; 2021 Jun; 40(6):4414-4421. PubMed ID: 33504454
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effect of
    Chen L; Xu WL; Pei LX; Wu XL; Geng H; Guo J; Sun JH
    Zhongguo Zhen Jiu; 2021 Feb; 41(2):137-41. PubMed ID: 33788460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.